The therapy delivers the full-length ABCA4 protein and has the potential to benefit all patients with ABCA4 mutations
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
FDA grants accelerated approval to zongertinib for HER2 TKD-Mutated Non-Squamous NSCLC
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
The submission is supported by positive results from the Phase 3 AMPLIFY trial
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
The performance was below anticipated levels, primarily due to external factors such as seasonal disruption that affected overall results
Roche also shared the design of its upcoming Phase III TRONTIER 1 and 2 trials investigating trontinemab in people with early symptomatic Alzheimer’s disease
NewCo’s pipeline includes five investigational medicines
Subscribe To Our Newsletter & Stay Updated
